NICOLE MORGAN: Open Payments
NPI 1083100036 · GRAND FORKS, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,685 in 69 payments from 34 companies in 2025. Trend: 2023 $0 · 2024 $1,851 · 2025 $4,685
Food & beverage: $2,581Travel & lodging: $2,085Gift: $20
| Company | Payments | Amount |
|---|---|---|
| OnMark, Inc. | 10 | $3,543 |
| Janssen Biotech, Inc. | 7 | $146 |
| Lilly USA, LLC | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 5 | $72 |
| Daiichi Sankyo Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| GENZYME CORPORATION | 1 | $48 |
| Eisai Inc. | 2 | $43 |
Products named: VERZENIO, Enhertu, KEYTRUDA, RYBREVANT, SARCLISA, TALVEY, REBLOZYL, Lenvima.
Industry payments across ND — which companies pay providers there.
